Directory

>

Seth Ettenberg

avatar

Seth Ettenberg

President and CEO | BlueRock Therapeutics

United States

View contact details (it's free)

Seth Ettenberg

Summary

Seth Ettenberg is a seasoned cell biologist and drug development expert, currently serving as the President and CEO of BlueRock Therapeutics. With a Ph.D. in Molecular and Cell Biology, Seth has dedicated his career to the pursuit of innovative therapies, particularly in oncology, driven by a personal mission to combat leukemia. His extensive experience spans leadership roles in both biotechnology and pharmaceutical industries, including positions at Novartis and Unum Therapeutics. Seth is known for his ability to inspire teams and drive scientific research towards practical applications in medicine. His work has contributed significantly to the development of antibody-coupled cellular immunotherapies, showcasing his commitment to transforming cancer treatment. Outside of his professional endeavors, he remains passionate about mentoring the next generation of scientists. Seth's journey reflects not only his technical expertise but also a profound personal connection to his work, making him a unique leader in the life sciences field.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Seth Ettenberg

Work Experience

company logo

President and CEO at

BlueRock Therapeutics

August 2021 - Present

company logo

Chief Scientific Officer at

BlueRock Therapeutics

March 2020 - August 2021

company logo

Chief Scientific Officer at

Cogent Biosciences

September 2014 - March 2020

company logo

Oncology Biotherapeutics, Head Cambridge Site at

Novartis

May 2009 - September 2014

company logo

Lab Head at

Novartis

June 2005 - May 2009

💼

Project Leader at

CuraGen Corporation

October 2001 - June 2005

company logo

Post-doctoral Fellow at

National Cancer Institute (NCI)

January 1999 - January 2001

Logos provided by Logo.dev

Seth Ettenberg

Education

Uniformed Services University, Ph.D.

January 1996 - January 2000

Frequently Asked Questions about Seth Ettenberg

What is Seth Ettenberg email address?

Seth Ettenberg's primary email address is **********@bluerocktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Seth Ettenberg work for?

Seth Ettenberg is a President and CEO at BlueRock Therapeutics, a company specializing in Commercial physical research.

Where Seth Ettenberg graduated from?

Seth Ettenberg holds a degree in Molecular And Cell Biology from Uniformed Services University.

How can I directly contact Seth Ettenberg?

To contact Seth Ettenberg directly, you can use the email address **********@bluerocktx.com. Complete contact information is available upon registration with Muraena.

Who is Seth Ettenberg?

Seth Ettenberg is a seasoned cell biologist and drug development expert, currently serving as the President and CEO of BlueRock Therapeutics. With a Ph.D. in Molecular and Cell Biology, Seth has dedicated his career to the pursuit of innovative therapies, particularly in oncology, driven by a personal mission to combat leukemia. His extensive experience spans leadership roles in both biotechnology and pharmaceutical industries, including positions at Novartis and Unum Therapeutics. Seth is known for his ability to inspire teams and drive scientific research towards practical applications in medicine. His work has contributed significantly to the development of antibody-coupled cellular immunotherapies, showcasing his commitment to transforming cancer treatment. Outside of his professional endeavors, he remains passionate about mentoring the next generation of scientists. Seth's journey reflects not only his technical expertise but also a profound personal connection to his work, making him a unique leader in the life sciences field.

Seth`s contact details

mail

**********@bluerocktx.com

**************@unumrx.com

**************@novartis.com

Colleagues

avatar
Norman Kim

Vice President, Preclinical Development & Clinical Pharmacology

avatar
Pratik Jaluria

SVP Process & Analytical Development

avatar
Angela Keightley

Vice President, Assay Development

avatar
Greg Motz

VP, Immunology

avatar
Ryan Hovda

Vice President, Vendor Strategy & Partnerships

Richard Reineke

Vice President, GMP Manufacturing

avatar
Rebecca Kauffman Milbury

Senior Vice President, Head of People & Culture

avatar
Natasha Rathee

SVP, Global Head of Finance

avatar
Stefan Irion

Chief Scientific Officer

avatar
Doug Kerr Md

Board Member and SAB

View Contact details (it's free)
Request Profile Removal